Ftse Mib
33.119,41
-1,46%
DAX
18.166,51
-0,53%
S&P 500
5.433,74
0,23%
NASDAQ
17.667,56
0,34%
Bitcoin
67.101,31
0,52%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG NurExone Biologic Inc (J90) NurExone Biologic Inc (J90) Notizie

NurExone Biologic Inc

J90
0,396
0,028 (7,61%)
10:23:59 - Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
11/6/202414:44GLOBENurExone Announces Expansion of ExoPTEN Patent Coverage with..
04/6/202422:40GLOBENurExone Announces Voting Results from 2024 Annual Meeting..
29/5/202414:35GLOBENurExone Reports First Quarter 2024 Financial Results and..
17/5/202422:04GLOBENurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive..
25/4/202414:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
19/4/202422:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
02/4/202414:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
27/3/202422:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
22/3/202422:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
15/3/202421:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
08/3/202422:05GLOBENurExone establishing State-of-the-Art Research and..
01/3/202422:04GLOBENurExone Presenting Novel Regulatory Pathways for Exosomes..
20/2/202422:05GLOBENurExone’s Intellectual Property Portfolio Expands
14/2/202422:20GLOBENurExone Launches Licensing Efforts for ExoTherapy Platform
02/2/202422:05GLOBENurexone Biologic Initiates European Orphan Drug Designation..
17/1/202414:34GLOBENurExone and Inteligex Kick Off Chronic Spinal Cord Injury..
05/1/202414:30GLOBENurExone Announces Closing of a Private Placement for Gross..
29/11/202314:30GLOBENurExone Biologic Extends Spinal Cord Injury Therapy..
24/11/202314:30GLOBENurExone Reports Third Quarter 2023 Financial Results and..
30/10/202314:20GLOBENurExone Biologic Receives FDA Orphan-Drug Designation,..
19/10/202314:30GLOBEAppointment of Professor Teo Forcht Dagi to Scientific..
11/10/202314:30GLOBENurExone Secures Eureka Grant for Collaborative..
05/10/202314:30GLOBENurExone Biologic to Present Exosome-Based Therapy for..
28/9/202314:30GLOBENurExone Appoints Dr. Reuter Investor Relations in Europe
13/9/202314:30GLOBENurExone Moves Forward Towards Human Clinical Trials,..
06/9/202314:30GLOBENurExone Announces Closing of Second Tranche of Private..
Apertura: 0,406 Min: 0,362 Max: 0,408
Chiusura: 0,368

La tua Cronologia

TG
J90
NurExone Biologic
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network